Plenary Lecture "The future created by quantum computing" PL01-01		[Big hall] 10/28 10:35-11:20
	Quantum Frontiers: Shaping the Future through Agile Dynamic Innovation
	Kazuya Masu
	Global Research and Development Center for Business by Quantum-AI Technology (G-QuAT), National Institute of Advanced Industrial Science and Technology

  Quantum technologies are advancing rapidly, bringing together diverse disciplines such as computer science, materials research, life sciences, and information theory. Their potential applications—from drug discovery and materials design to optimization, secure communication, and sensing—are narrowing the gap between fundamental research and societal implementation.
  In this keynote, we will explore the concept of the “quantum frontier” not merely as a technological challenge, but as a space for dynamic knowledge creation, where basic science, research, application, and innovation evolve concurrently. The activities of G-QuAT (Global Research and Development Center for Business by Quantum-AI Technology) will be introduced: G-QuAT fosters convergence across disciplines, supports use-case development, and promotes the formation of an international ecosystem for quantum advancement.
  Rather than viewing quantum as a linear path from theory to application, we propose an Agile Dynamic Society—where researchers, engineers, policymakers, and users collaboratively shape the future in real time. This shift invites academia to engage in new modes of cross-disciplinary collaboration and co-creation.
  Quantum technologies are not just transformative tools; they are catalysts for reimagining how knowledge meets society. We hope this talk will inspire fruitful dialogue and creative intersections across fields.

Plenary Lecture "The future created by quantum computing" PL01-02		[Big hall] 10/28 11:20-11:45
	Chugai’s vision and initiatives on quantum computing
	Akihiko Arakawa
	Chugai Pharmaceutical Co., Ltd.

  As drug discovery and development become increasingly challenging, the utilization of advanced digital technologies aimed at shortening timelines, reducing costs, and improving success rates is gaining momentum. Quantum computers, leveraging quantum mechanical principles, hold the potential to solve problems intractable for classical computers. While several proof-of-concept (PoC) studies in drug discovery and development have been reported, significant hurdles to the practical application of quantum computing still persist, including scalability, qubit stability, and error correction. Consequently, developing practical algorithms and applications that demonstrate quantum advantage remains a significant challenge. In the near future, fault-tolerant quantum computers are expected to emerge, raising expectations for practical application to drug discovery and development.
  At Chugai, while maintaining our fundamental stance of monitoring quantum computing trends, we have conducted PoC studies in collaboration with external partners for use cases aligned with our R&D strategy. In this presentation, we will introduce Chugai's vision and initiatives regarding quantum computing, addressing the gap between the current state of quantum technology and the expectations from pharmaceutical R&D, as well as our perspective on future technological advancements.